BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 9247316)

  • 1. Characterization of murine Flt4 ligand/VEGF-C.
    Fitz LJ; Morris JC; Towler P; Long A; Burgess P; Greco R; Wang J; Gassaway R; Nickbarg E; Kovacic S; Ciarletta A; Giannotti J; Finnerty H; Zollner R; Beier DR; Leak LV; Turner KJ; Wood CR
    Oncogene; 1997 Jul; 15(5):613-8. PubMed ID: 9247316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases.
    Joukov V; Pajusola K; Kaipainen A; Chilov D; Lahtinen I; Kukk E; Saksela O; Kalkkinen N; Alitalo K
    EMBO J; 1996 Jan; 15(2):290-98. PubMed ID: 8617204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Signalling properties of FLT4, a proteolytically processed receptor tyrosine kinase related to two VEGF receptors.
    Pajusola K; Aprelikova O; Pelicci G; Weich H; Claesson-Welsh L; Alitalo K
    Oncogene; 1994 Dec; 9(12):3545-55. PubMed ID: 7970715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biochemical characterization of two isoforms of FLT4, a VEGF receptor-related tyrosine kinase.
    Borg JP; deLapeyrière O; Noguchi T; Rottapel R; Dubreuil P; Birnbaum D
    Oncogene; 1995 Mar; 10(5):973-84. PubMed ID: 7898938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The FLT4 gene encodes a transmembrane tyrosine kinase related to the vascular endothelial growth factor receptor.
    Galland F; Karamysheva A; Pebusque MJ; Borg JP; Rottapel R; Dubreuil P; Rosnet O; Birnbaum D
    Oncogene; 1993 May; 8(5):1233-40. PubMed ID: 8386825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutation at tyrosine residue 1337 abrogates ligand-dependent transforming capacity of the FLT4 receptor.
    Fournier E; Dubreuil P; Birnbaum D; Borg JP
    Oncogene; 1995 Sep; 11(5):921-31. PubMed ID: 7675451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FLT4 receptor tyrosine kinase contains seven immunoglobulin-like loops and is expressed in multiple human tissues and cell lines.
    Pajusola K; Aprelikova O; Korhonen J; Kaipainen A; Pertovaara L; Alitalo R; Alitalo K
    Cancer Res; 1992 Oct; 52(20):5738-43. PubMed ID: 1327515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular endothelial growth factor (VEGF)-C synergizes with basic fibroblast growth factor and VEGF in the induction of angiogenesis in vitro and alters endothelial cell extracellular proteolytic activity.
    Pepper MS; Mandriota SJ; Jeltsch M; Kumar V; Alitalo K
    J Cell Physiol; 1998 Dec; 177(3):439-52. PubMed ID: 9808152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Missense mutations interfere with VEGFR-3 signalling in primary lymphoedema.
    Karkkainen MJ; Ferrell RE; Lawrence EC; Kimak MA; Levinson KL; McTigue MA; Alitalo K; Finegold DN
    Nat Genet; 2000 Jun; 25(2):153-9. PubMed ID: 10835628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two human FLT4 receptor tyrosine kinase isoforms with distinct carboxy terminal tails are produced by alternative processing of primary transcripts.
    Pajusola K; Aprelikova O; Armstrong E; Morris S; Alitalo K
    Oncogene; 1993 Nov; 8(11):2931-7. PubMed ID: 7692369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A single autophosphorylation site on KDR/Flk-1 is essential for VEGF-A-dependent activation of PLC-gamma and DNA synthesis in vascular endothelial cells.
    Takahashi T; Yamaguchi S; Chida K; Shibuya M
    EMBO J; 2001 Jun; 20(11):2768-78. PubMed ID: 11387210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of VEGF and VEGF receptor expression in the rodent mammary gland during pregnancy, lactation, and involution.
    Pepper MS; Baetens D; Mandriota SJ; Di Sanza C; Oikemus S; Lane TF; Soriano JV; Montesano R; Iruela-Arispe ML
    Dev Dyn; 2000 Jul; 218(3):507-24. PubMed ID: 10878616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular cloning of murine FLT and FLT4.
    Finnerty H; Kelleher K; Morris GE; Bean K; Merberg DM; Kriz R; Morris JC; Sookdeo H; Turner KJ; Wood CR
    Oncogene; 1993 Aug; 8(8):2293-8. PubMed ID: 8393164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complete inhibition of vascular endothelial growth factor (VEGF) activities with a bifunctional diabody directed against both VEGF kinase receptors, fms-like tyrosine kinase receptor and kinase insert domain-containing receptor.
    Lu D; Jimenez X; Zhang H; Wu Y; Bohlen P; Witte L; Zhu Z
    Cancer Res; 2001 Oct; 61(19):7002-8. PubMed ID: 11585724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel vascular endothelial growth factor encoded by Orf virus, VEGF-E, mediates angiogenesis via signalling through VEGFR-2 (KDR) but not VEGFR-1 (Flt-1) receptor tyrosine kinases.
    Meyer M; Clauss M; Lepple-Wienhues A; Waltenberger J; Augustin HG; Ziche M; Lanz C; Büttner M; Rziha HJ; Dehio C
    EMBO J; 1999 Jan; 18(2):363-74. PubMed ID: 9889193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-VEGFR-2 scFvs for cell isolation. Single-chain antibodies recognizing the human vascular endothelial growth factor receptor-2 (VEGFR-2/flk-1) on the surface of primary endothelial cells and preselected CD34+ cells from cord blood.
    Böldicke T; Tesar M; Griesel C; Rohde M; Gröne HJ; Waltenberger J; Kollet O; Lapidot T; Yayon A; Weich H
    Stem Cells; 2001; 19(1):24-36. PubMed ID: 11209088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular endothelial growth factor-related protein: a ligand and specific activator of the tyrosine kinase receptor Flt4.
    Lee J; Gray A; Yuan J; Luoh SM; Avraham H; Wood WI
    Proc Natl Acad Sci U S A; 1996 Mar; 93(5):1988-92. PubMed ID: 8700872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the VEGF binding site on the Flt-1 receptor.
    Herley MT; Yu Y; Whitney RG; Sato JD
    Biochem Biophys Res Commun; 1999 Sep; 262(3):731-8. PubMed ID: 10471394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterogeneous vascular endothelial growth factor (VEGF) isoform mRNA and receptor mRNA expression in human glomeruli, and the identification of VEGF148 mRNA, a novel truncated splice variant.
    Whittle C; Gillespie K; Harrison R; Mathieson PW; Harper SJ
    Clin Sci (Lond); 1999 Sep; 97(3):303-12. PubMed ID: 10464055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Purification and refolding of vascular endothelial growth factor-B.
    Scrofani SD; Fabri LJ; Xu P; Maccarone P; Nash AD
    Protein Sci; 2000 Oct; 9(10):2018-25. PubMed ID: 11106176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.